Recent Finacing
Recent Raise
NEXT Life Sciences develops Plan A, a device-based, non-hormonal, long-acting reversible male contraceptive that inserts Vasalgel® hydrogel into the vas deferens to block and later restore sperm flow.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
